Cardiac resynchronization therapy: results, challenges and perspectives for the future

References

• Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–2200.
   PubMed Web of Science ®Google Scholar
• Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J. 2002;143:398–405.
   PubMed Web of Science ®Google Scholar
• Gorcsan J 3rd, Prinzen FW. Understanding the cardiac substrate and the underlying physiology: implications for individualized treatment algorithm. Heart Rhythm. 2012;9:S18–S26.
   Google Scholar
• Spragg DD, Leclercq C, Loghmani M, et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation. 2003;108:929–932.
   PubMed Web of Science ®Google Scholar
• Kirk JA, Kass DA. Cellular and molecular aspects of dyssynchrony and resynchronization. Card Electrophysiol Clin. 2015;7:585–597.
   PubMedGoogle Scholar
• Vanderheyden M, Mullens W, Delrue L, et al. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol. 2008;51:129–136.
   PubMed Web of Science ®Google Scholar
• Braunschweig F, Sorensen J, von Bibra H, et al. Effects of biventricular pacing on myocardial blood flow and oxygen consumption using carbon-11 acetate positron emission tomography in patients with heart failure. Am J Cardiol. 2003;92:95–99.
   PubMed Web of Science ®Google Scholar
• van Oosterhout MF, Prinzen FW, Arts T, et al. Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation. 1998;98:588–595.
   PubMed Web of Science ®Google Scholar
• Brunekreeft JA, Graauw M, de Milliano PA, et al. Influence of left bundle branch block on left ventricular volumes, ejection fraction and regional wall motion. Neth Heart J. 2007;15:89–94.
   PubMed Web of Science ®Google Scholar
• Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52:1834–1843.
   PubMed Web of Science ®Google Scholar
• Stahlberg M, Lund LH, Zabarovskaja S, et al. Cardiac resynchronization therapy: a breakthrough in heart failure management. J Intern Med. 2012;272:330–343.
   PubMed Web of Science ®Google Scholar
• Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The pacing therapies for congestive heart failure study group. The guidant congestive heart failure research group. Circulation. 1999;99:2993–3001.
   PubMed Web of Science ®Google Scholar
• Vollmann D, Luthje L, Schott P, et al. Biventricular pacing improves the blunted force-frequency relation present during univentricular pacing in patients with heart failure and conduction delay. Circulation. 2006;113:953–959.
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–1549.
   PubMed Web of Science ®Google Scholar
• Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385–2395.
   PubMed Web of Science ®Google Scholar
• Goldenberg I, Kutyifa V, Klein HU, et al. Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med. 2014;370:1694–1701.
   PubMed Web of Science ®Google Scholar
• Cha YM, Oh J, Miyazaki C, et al. Cardiac resynchronization therapy upregulates cardiac autonomic control. J Cardiovasc Electrophysiol. 2008;19:1045–1052.
   PubMed Web of Science ®Google Scholar
• Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873–880.
   PubMed Web of Science ®Google Scholar
• Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40:111–118.
   PubMed Web of Science ®Google Scholar
• Auricchio A, Stellbrink C, Butter C, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42:2109–2116.
   PubMed Web of Science ®Google Scholar
• Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42:1454–1459.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–1853.
   PubMed Web of Science ®Google Scholar
• Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685–2694.
   PubMed Web of Science ®Google Scholar
• Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150.
   PubMed Web of Science ®Google Scholar
• Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329–1338.
   PubMed Web of Science ®Google Scholar
• Cleland JG, Abraham WT, Linde C, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013;34:3547–3556.
   PubMed Web of Science ®Google Scholar
• Ruschitzka F, Abraham WT, Singh JP, et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013;369:1395–1405.
   PubMed Web of Science ®Google Scholar
• Linde C, Abraham WT, Gold MR, et al. Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study. J Am Coll Cardiol. 2010;56:1826–1831.
   PubMed Web of Science ®Google Scholar
• Wikstrom G, Blomstrom-Lundqvist C, Andren B, et al. The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J. 2009;30:782–788.
   PubMed Web of Science ®Google Scholar
• Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91:2D–8D.
   PubMed Web of Science ®Google Scholar
• Koplan BA, Kaplan AJ, Weiner S, et al. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol. 2009;53:355–360.
   PubMed Web of Science ®Google Scholar
• Brignole M, Botto G, Mont L, et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J. 2011;32:2420–2429.
   PubMed Web of Science ®Google Scholar
• Upadhyay GA, Choudhry NK, Auricchio A, et al. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2008;52:1239–1246.
   PubMed Web of Science ®Google Scholar
• Wilton SB, Leung AA, Ghali WA, et al. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2011;8:1088–1094.
   PubMed Web of Science ®Google Scholar
• Zabarovskaja S, Gadler F, Braunschweig F, et al. Women have better long-term prognosis than men after cardiac resynchronization therapy. Europace. 2012;14:1148–1155.
   PubMed Web of Science ®Google Scholar
• Mathew J, Katz R, St John Sutton M, et al. Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study. Eur J Heart Fail. 2012;14:1420–1428.
   PubMed Web of Science ®Google Scholar
• Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European society of cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34:2281–2329.
   PubMed Web of Science ®Google Scholar
• Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol. 2012;59:1509–1518.
   PubMed Web of Science ®Google Scholar
• Saba S, Marek J, Schwartzman D, et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the speckle tracking assisted resynchronization therapy for electrode region trial. Circ Heart Fail. 2013;6:427–434.
   PubMed Web of Science ®Google Scholar
• Pappone C, Calovic Z, Vicedomini G, et al. Multipoint left ventricular pacing improves acute hemodynamic response assessed with pressure-volume loops in cardiac resynchronization therapy patients. Heart Rhythm. 2014;11:394–401.
   PubMed Web of Science ®Google Scholar
• Pappone C, Calovic Z, Vicedomini G, et al. Multipoint left ventricular pacing in a single coronary sinus branch improves mid-term echocardiographic and clinical response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2015;26:58–63.
   PubMed Web of Science ®Google Scholar
• Behar JM, Bostock J, Zhu Li AP, et al. Cardiac resynchronization therapy delivered via a multipolar left ventricular lead is associated with reduced mortality and elimination of phrenic nerve stimulation: long-term follow-up from a multicenter registry. J Cardiovasc Electrophysiol. 2015;26:540–546.
   PubMed Web of Science ®Google Scholar
• Sawhney NS, Waggoner AD, Garhwal S, et al. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm. 2004;1:562–567.
   PubMed Web of Science ®Google Scholar
• Ellenbogen KA, Gold MR, Meyer TE, et al. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation. 2010;122:2660–2668.
   PubMed Web of Science ®Google Scholar
• Leon AR, Abraham WT, Brozena S, et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. J Am Coll Cardiol. 2005;46:2298–2304.
   PubMed Web of Science ®Google Scholar
• Stahlberg M, Hilpisch K, Reiters P, et al. Haemodynamic effects of different basic heart rates in ambulatory heart failure patients treated with cardiac resynchronization therapy. Europace. 2013;15:1182–1190.
   PubMed Web of Science ®Google Scholar
• Stahlberg M, Sander M, Mortensen L, et al. Increase in paced heart rate reduces muscle sympathetic nerve activity in heart failure patients treated with cardiac resynchronization therapy. Europace. 2015;17:439–446.
   PubMed Web of Science ®Google Scholar
• Loh JC, Creaser J, Rourke DA, et al. Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center. Circ Heart Fail. 2013;6:411–419.
   PubMed Web of Science ®Google Scholar
• Bogale N, Priori S, Cleland JG, et al. The European CRT survey: 1 year (9-15 months) follow-up results. Eur J Heart Fail. 2012;14:61–73.
   PubMed Web of Science ®Google Scholar
• Thorvaldsen T, Benson L, Dahlstrom U, et al. Use of evidence-based therapy and survival in heart failure in Sweden 2003–2012. Eur J Heart Fail. 2016;18:503–511.
   PubMed Web of Science ®Google Scholar
• Lund LH, Benson L, Stahlberg M, et al. Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish heart failure registry. Eur J Heart Fail. 2014;16:1073–1081.
   PubMed Web of Science ®Google Scholar
• Braunschweig F, Linde C, Benson L, et al. New York heart association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy. Eur J Heart Fail. 2016. doi:10.1002/ejhf.563.
   Google Scholar
• Linde C, Stahlberg M, Benson L, et al. Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure. Europace. 2015;17:424–431.
   PubMed Web of Science ®Google Scholar
• Hubinette C, Lund LH, Gadler F, et al. Awareness of indications for device therapy among a broad range of physicians: a survey study. Europace. 2014;16:1580–1586.
   PubMed Web of Science ®Google Scholar
• Prinzen FW, Peschar M. Relation between the pacing induced sequence of activation and left ventricular pump function in animals. Pacing Clin Electrophysiol. 2002;25:484–498.
   PubMed Web of Science ®Google Scholar
• Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA. 2002;288:3115–3123.
   PubMed Web of Science ®Google Scholar
• Hoijer CJ, Meurling C, Brandt J. Upgrade to biventricular pacing in patients with conventional pacemakers and heart failure: a double-blind, randomized crossover study. Europace. 2006;8:51–55.
   PubMed Web of Science ®Google Scholar
• Reddy VY, Exner DV, Cantillon DJ, et al. Percutaneous Implantation of an entirely intracardiac leadless pacemaker. N Engl J Med. 2015;373:1125–1135.
   PubMed Web of Science ®Google Scholar
• Houthuizen P, Van Garsse LA, Poels TT, et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation. 2012;126:720–728.
   PubMed Web of Science ®Google Scholar
• Dizon JM, Nazif TM, Hess PL, et al. Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart. 2015;101:1665–1671.
   PubMed Web of Science ®Google Scholar